Delamanid, a new 6-nitro-2,3-dihydroimidazo[2,1-b]oxazole for the management of tuberculosis resistant to at least isoniazid and rifampicin-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Delamanid, a new 6-nitro-2,3-dihydroimidazo[2,1-b]oxazole for the management of tuberculosis resistant to at least isoniazid and rifampicin

Published:2013-11-25 Issue:1 Volume:2 Page:87-94
ISSN:2167-8707
Container-title:Expert Opinion on Orphan Drugs
language:en
Short-container-title:Expert Opinion on Orphan Drugs

Author:

Diacon Andreas H,von Groote-Bidlingmaier Florian,Donald Peter R

Publisher

Informa Healthcare

Subject

Pharmacology (medical),Health Policy,Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Link

http://www.tandfonline.com/doi/pdf/10.1517/21678707.2014.863729

Reference27 articles.

1. Screening for Novel Antituberculosis Agents that are Effective Against Multidrug Resistant Tuberculosis

2. Early bactericidal activity of delamanid (OPC-67683) in smear-positive pulmonary tuberculosis patients

3. Delamanid for Multidrug-Resistant Pulmonary Tuberculosis

4. Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis

5. Metronidazole is bactericidal to dormant cells of Mycobacterium tuberculosis

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Curious effects of fluorine on medicinally active compounds;The Curious World of Fluorinated Molecules;2021

2. Case studies of fluorine in drug discovery;Fluorine in Life Sciences: Pharmaceuticals, Medicinal Diagnostics, and Agrochemicals;2019

3. The Current Status of O-Heterocycles: A Synthetic and Medicinal Overview;ChemMedChem;2018-04-25

4. PERSPECTIVES OF TARGETED CHEMOTHERAPY WITH DELAMANID IN THE TREATMENT REGIMENS OF THOSE WITH MULTIPLE/EXTENSIVE DRUG RESISTANT TUBERCULOSIS. A SUCCESS, CHANCE OR UNCERTAINTY?;TUBERCULOSIS AND LUNG DISEASES;2018

5. Synthesis and Antioxidant Properties of New Oxazole-5(4H)-one Derivatives;Turkish Journal of Pharmaceutical Sciences;2017-08-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3